COPD Treatment in Real Life and Randomized Controlled Trials: Is There Any Difference between Both Settings?

Journal Title: Chronic Obstructive Pulmonary Disease: Open Access - Year 2017, Vol 2, Issue 1

Abstract

In the last decade, for treatment of patients with chronic obstructive pulmonary disease (COPD) a myriad of new medications, mostly administered in new inhalation devices were introduced on the market. In addition, All, but one (Roflumilast) of these “new” drugs rely on old and well proven principles of long acting bronchodilation. Nonetheless, for gaining regulatory approval many randomized controlled trials (RCT’s) were accomplished for long-acting beta2 agonists (LABA’s) and long-acting anticholinergics (LAMA’s) and their fixed combinations, respectively, Inhaled corticosteroids (ICS) as anti-inflammatory therapy are available on the market for a long time, but their indication for COPD is controversial [1,2] and new fixed combinations emerged. Hence even more RCT’s for pharmacological treatment of COPD were recently completed. Therefore, enough high grade evidence from RCT’s should exist for pharmacological treatment of COPD patients.

Authors and Affiliations

Peter Kardos

Keywords

Related Articles

Thrombomodulin for Acute Exacerbations of Idiopathic Pulmonary Fibrosis

Background: Acute exacerbation (AE) is known as a leading cause of morbidity and mortality in chronic fibrosing group includes idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP). There is n...

Acute Effects of Inspiratory Muscle Training on Pulmonary Arterial Pressure,Cardiac Output and Pulmonary Arterial Saturation Derived Oxygen Cost of Breathing

Respiration and respiratory maneuvers affect cardiac output. Inspiratory muscle training (IMT) increases the negative thoracic pressure, which could have an impact on intra-thoracic hemodynamics and thereby influence the...

Relation between Cor Pulmonale Status and Metrics of Six Minute Walk Test in Patients with Chronic Obstructive Pulmonary Disease: A Cross Sectional Study

Background: Cor pulmonale is a complication of chronic obstructive pulmonary disease (COPD). The use of the six minute walk test (6MWT) to discriminate between COPD patients with and without cor pulmonale remains unclear...

Minute lesions of alveolar damages in lungs of patients with stable chronic obstructive pulmonary disease

Objective: To reveal the mechanism underlying recruitment of neutrophils in chronic obstructive pulmonary disease (COPD) lungs and to investigate the role of minute lesions of alveolar damage (MLADs) in emphysema develop...

Characterization of Smoking Habits Patterns in Medical Doctors of a Central Hospital in Portugal–What has Changed after 15 Years? A Comparative CrossSectional Study

Introduction: Tobacco dependence remains one of the primary health care concerns worldwide. Attitude of healthcare professionals towards smoking is crucial for any long-term prevention and smoking cessation program. Obj...

Download PDF file
  • EP ID EP304098
  • DOI 10.21767/2572-5548.100020
  • Views 21
  • Downloads 0

How To Cite

Peter Kardos (2017). COPD Treatment in Real Life and Randomized Controlled Trials: Is There Any Difference between Both Settings?. Chronic Obstructive Pulmonary Disease: Open Access, 2(1), 1-2. https://europub.co.uk/articles/-A-304098